|
V.I. Kudinov, M.S. Nichitenko, A.I. Chesnikova
THERAPY WITH LIRAGLUTIDE SIGNIFICANTLY IMPROVES GLYCEMIC CONTROL AND HAS POSITIVE IMPACT ON THE CARDIOVASCULAR SYSTEM OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
|
13-18 |
|
M.Sh. Abaeva, P.K. Nazhmutdinova, A.S. Ametov
INFLUENCE METFORMIN AND VILDAGLIPTIN ON CARBOHYDRATE AND FAT METABOLISM IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
|
19-25 |
|
M.B. Antsiferov (1), V.S. Pronin (2)
ANTITUMOR EFFECTS OF SOMATOSTATIN ANALOGUES IN SOMATOTROPH PITUITARY ADENOMAS: REVIEW OF RECENT RESEARCH
|
26-31 |
|
А.А. Yuryatin
THE SAVOR TRIAL: THE BEGINNING OF THE NEW ERA OF SAFE PHARMACOTHERAPY FOR TYPE-2 DIABETES MELLITUS
|
32-35 |
|
G.R. Galstyan
DETERMINATION OF GLYCEMIA IN THE SETTINGS OF MEDICAL PREVENTIVE INSTITUTION
|
36-39 |
|
E.V. Biryukova
CENTRAL DIABETES INSIPIDUS: WHAT IS THE SECRET OF TREATMENT EFFECTIVENESS?
|
40-46 |
|
N.A. Petunina , I.A. Kuzina
METFORMIN - A RELIABLE PARTNER IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
|
47-52 |
|
M.E.Statsenko (1), A.A.Vinnikova (1), N.N.Shilina (1), A.M.Ronskaya (2)
POTENTIALS OF DIBICOR IN IN CORRECTION OF METABOLIC AND VASCULAR ABNORMALITIES IN PATIENTS WITH CHRONIC HEART FAILURE AND TYPE 2 DIABETES MELLITUS
|
53-60 |
|
O.L.Badalyan , A.A.Savenkov
PATHOGENETIC APPROACHES TO THE THERAPY OF DIABETIC POLYNEUROPATHY
|
61-65 |
|
L.A. Sharonova (1), A.F. Verbovoy (1), D.Yu. Sharonova (2)
CLINICAL MANIFESTATION, DIAGNOSIS AND TREATMENT OF DIABETIC NEUROPATHY
|
66-71 |
|
I.A. Kurnikova
FOROSA IN THE THERAPY OF CALCIUM AND PHOSPHORUS METABOLISM DISORDERS IN ENDOCRINOLOGICAL PATIENTS
|
72-80 |
|
M.B. Antsiferov, O.M. Koteshkova
DIABETES MANAGEMENT: THE IMPORTANCE OF STRUCTURED SELF-CONTROL
|
81-85 |
|
I.V. Kononenko, O.M. Smirnova
DIABETES MELLITUS: FROM UNDERSTANDING OF CAUSES TO THE CHOICE OF TREATMENT
|
86-93 |
|
N.Yu. Arbatskaya (1,2)
FEATURES OF GLUCOSE-LOWERING TREATMENT DURING PREGNANCY
|
94-99 |
|
Yu.E. Azimova (1,2)
DIABETIC POLYNEUROPATHY: APPROACHES TO THE THERAPY
|
100-103 |
Русский
